Neurophet Showcases Innovative tDCS Solutions at International Brain Stimulation Conference in Kobe

Neurophet's Breakthrough at the Brain Stimulation Conference

Neurophet, an innovative company specializing in artificial intelligence solutions for brain disorders, made significant strides at the 6th International Brain Stimulation Conference held in Kobe, Japan. Co-CEOs Jake Junkil Been and Donghyeon Kim led the presentation of three key research abstracts focused on personalized transcranial Direct Current Stimulation (tDCS).

Presentation Highlights

The conference, running from February 23 to February 26, provided an esteemed platform for Neurophet to present its findings on the safety and efficacy of personalized tDCS in treating critical brain disorders. The abstracts highlighted the following areas:
1. Upper Extremity Function in Stroke Patients: Safety and effectiveness in patients who experienced sub-acute and chronic strokes.
2. Consciousness Recovery: Effectiveness in patients suffering from prolonged disorders of consciousness through tailored tDCS solutions.
3. Dysphagia Post-Stroke: An innovative MRI-based optimization technique for treating post-stroke dysphagia using tDCS.

The personalized tDCS technology presented is not just another neurostimulation device; it represents a leap forward in how brain stimulation therapies are approached.